Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
This study is testing if a treatment called CARAT, which combines language therapy and robot-assisted arm therapy, can help people who have had a stroke improve their language and arm movements. Researchers want to see if CARAT works better than just robot-assisted arm therapy alone. You might be able to join if you are 18-90 years old, right-handed before your stroke, speak English, had a stroke on the left side of your brain at least 6 months ago, and have aphasia (difficulty with language) and problems naming things. The study will measure improvements in naming ability using the Philadelphia Naming Test and arm movement using the Fugl-Meyer Upper Extremity Motor Assessment.
- Study design
- This study is comparing two treatments in about 28 participants. It's an interventional study, meaning participants will receive a specific treatment.
- What's involved
- Participants will receive 18 sessions of either combined aphasia and robot-assisted arm therapy (CARAT) or robot-assisted arm therapy alone.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your language and arm movements will be measured at the start of the study and again one week after your treatment ends.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
At a glance
Conditions
NCT07000019
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Westchester Medical Center / New York Medical College
Valhalla, New Yorkstudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Tomoko Kitago, MD · PRINCIPAL_INVESTIGATOR · Westchester Medical Center / New York Medical College
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Philadelphia Naming TestBaseline to 1 week post-treatment
- Fugl-Meyer Upper Extremity Motor AssessmentBaseline to 1 week post-treatment